CDTX•benzinga•
RBC Capital Maintains Outperform on Cidara Therapeutics, Raises Price Target to $35
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 23, 2025 by benzinga